Trevena Announces Advancement of TRV045 Into Clinical Development for Diabetic Neuropathic Pain

NEXT STORY
TG Therapeutics Announces Data Presentations at the 63rd American Society of Hematology (ASH) Annual Meeting
PREV STORY
Teleflex Receives Reimbursement Approval for the UroLift® System in Japan
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

iCAD to Participate in B. Riley Securities Virtual Oncology Investor Conference

author_avatar
NASDAQ Market News

Fibrocell Announces FDA Allowance of Investigational New Drug Application for FCX-013 for the Treatment of Moderate to Severe Localized Scleroderma

author_avatar
NASDAQ Market News

Silencil Reviews: Negative Side Effects or Real Ingredients?

author_avatar
NASDAQ Market News